Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer

Published:2017-06-19 Issue:18 Volume:23 Page:5527-5536
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Malchers Florian,Ercanoglu Meryem,Schütte Daniel,Castiglione Roberta,Tischler Verena,Michels Sebastian,Dahmen Ilona,Brägelmann Johannes,Menon Roopika,Heuckmann Johannes M.,George Julie,Ansén Sascha,Sos Martin L.,Soltermann Alex,Peifer Martin,Wolf Jürgen,Büttner Reinhard,Thomas Roman K.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary;Molecular Therapy;2024-07

2. Oncogene alterations in non-small cell lung cancer with FGFR1 amplification—novel approach to stratify patients who benefit from FGFR inhibitors;Translational Lung Cancer Research;2024-03

3. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions;Nature Reviews Clinical Oncology;2024-02-29

4. Role of FGFR3 in bladder cancer: Treatment landscape and future challenges;Cancer Treatment Reviews;2023-04

5. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention;Journal of Biomolecular Structure and Dynamics;2023-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP